🔎 Trials Near Me

Akèy › Twoub depresif majè › Massachusetts › Boston

Etid klinik pou Twoub depresif majè nan Boston, MA

31 etid pou Twoub depresif majè ap chèche patisipan nan sit nan ak bò kote Boston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

Ap rekriteFaz 3
  • Adams Clinical Boston, Boston
Laj 18 a 85 · Tout sèks · Mizajou Oct 5, 2026 · NCT06793397

A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)

Ap rekriteFaz 3
  • Adams Clinical Watertown, Boston
Laj 18 a 74 · Tout sèks · Mizajou Oct 5, 2026 · NCT07592689

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

Ap rekriteFaz 3
  • Adams Clinical Boston, Boston
Laj 18 a 75 · Tout sèks · Mizajou Oct 5, 2026 · NCT07412756

A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder

Ap rekriteFaz 3
  • Adams Clinical Boston, Boston
Laj 18 a 74 · Tout sèks · Mizajou Oct 1, 2026 · NCT07573176

A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder

Ap rekriteFaz 3
  • Adams Clinical Boston, Boston
Laj 18 a 75 · Tout sèks · Mizajou Oct 1, 2026 · NCT07775300

A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder

Ap rekriteFaz 3
  • Boston Childrens Hospital, Boston
Laj 12 a 17 · Tout sèks · Mizajou Sep 25, 2026 · NCT07227454

Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder

Ap rekriteFaz 3
  • Vanda Investigational Site, Boston
Laj 18 a 65 · Tout sèks · Mizajou Sep 24, 2026 · NCT06830044

Accelerated TMS for Perinatal Depression

Ap rekrite
  • Brigham and Women's Hospital, Boston
Laj 18 a 55 · Fanm · Mizajou Sep 18, 2026 · NCT06968390

A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

Ap rekriteFaz 2
  • Seaport Investigator Site, Boston
Laj 18 a 65 · Tout sèks · Mizajou Sep 14, 2026 · NCT07065240

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

Ap rekriteFaz 3
  • Adams Clinical Boston, Boston
Laj 18 a 74 · Tout sèks · Mizajou Sep 8, 2026 · NCT07076407

A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

Ap rekriteFaz 2
  • Draig Clinical Site, Boston
Laj 18 a 75 · Tout sèks · Mizajou Sep 2, 2026 · NCT07610473

Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)

Ap rekrite
  • Massachusetts General Hospital, Boston
  • Beth Israel Deaconess Medical Center, Boston
Laj 22 a 70 · Tout sèks · Mizajou Aug 28, 2026 · NCT06423430

Home-Based tDCS Treatment Of Major Depressive Disorder

Ap rekrite
  • Curavit Clinical Research (virtual study site), Boston
Laj 22 a 70 · Tout sèks · Mizajou Aug 14, 2026 · NCT06976697

The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder

Ap rekriteFaz 3
  • Athinoula A. Martinos Center for Biomedical Imaging, Charlestown · 1 mi lwen
Laj 18 a 55 · Tout sèks · Mizajou Aug 13, 2026 · NCT06247839

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

Ap rekriteFaz 3
  • Boston Clinical Trials Llc, Boston
Laj 18 a 74 · Tout sèks · Mizajou Aug 3, 2026 · NCT06775379

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Ap rekriteFaz 3
  • Neurocrine Clinical Site, Boston
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT06966401

Triage Survey for Psychiatry Research Eligibility

Ap rekriteEtid obsèvasyon
  • Adams Clinical, Boston, Boston
Laj 18 ak plis · Tout sèks · Mizajou May 20, 2026 · NCT05800925

Mechanisms Of Orbitofrontal Stimulation in Depression

Ap rekrite
  • Beth Israel Deaconess Medical Center, Boston
Laj 18 a 65 · Tout sèks · Mizajou May 14, 2026 · NCT07230990

REVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic Tool

Ap rekriteFaz 3Volontè an sante akeyi
  • Lindus Health (Virtual Study Site), Boston
Laj 18 ak plis · Tout sèks · Mizajou Apr 29, 2026 · NCT07280065

Mindfulness-Based fMRI Neurofeedback for Depression

Ap rekrite
  • Northeastern University, Boston
Laj 13 a 18 · Tout sèks · Mizajou Apr 29, 2026 · NCT05617495

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

Ap rekriteEtid obsèvasyon
  • Beth Israel Deaconess Medical Center, Boston
Laj 18 a 40 · Tout sèks · Mizajou Mar 10, 2026 · NCT06740383

Transcranial Near Infrared Radiation and Cerebral Blood Flow in Depression - R33

Ap rekrite
  • Harvard Medical School, Boston
Laj 18 a 65 · Tout sèks · Mizajou Feb 5, 2026 · NCT05573074

Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)

Ap rekriteFaz 2
  • Autobahn Site #137, Boston
Laj 18 a 65 · Tout sèks · Mizajou Jan 20, 2026 · NCT06633016

Long-Term Maintenance With Ketamine and Esketamine for Reduction of Suicide in High-Risk Patients With Depression

Ap rekriteFaz 4
  • Massachusetts General Hospital, Boston
Laj 18 a 70 · Tout sèks · Mizajou Dec 12, 2025 · NCT05450432

Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Ap rekriteFaz 3
  • Neurocrine Clinical Site, Boston
Laj 18 ak plis · Tout sèks · Mizajou Oct 29, 2025 · NCT06786624

Targeting Specific Brain Networks to Treat Specific Symptoms in Depression

Ap rekriteVolontè an sante akeyi
  • Massachusetts General Hospital, Boston
Laj 18 a 65 · Tout sèks · Mizajou Sep 29, 2025 · NCT05523817

Neuroactive Steroid to Treat Depressed Mood: A Trial for People With HIV

Ap rekriteFaz 2
  • Massachusetts General Hospital, Boston
Laj 18 a 85 · Tout sèks · Mizajou Sep 12, 2025 · NCT05570812

Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations

Ap rekriteVolontè an sante akeyi
  • Massachusetts General Hospital, Boston
Laj 18 a 65 · Tout sèks · Mizajou Sep 10, 2025 · NCT04296604

Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab

Ap rekriteFaz 2
  • Massachusetts General Hospital, Boston
Laj 25 a 50 · Tout sèks · Mizajou May 7, 2025 · NCT06136546

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

Ap rekriteFaz 4
  • Clinical Research Site, Boston
Laj 18 a 65 · Tout sèks · Mizajou Jan 23, 2025 · NCT06223880

Peripheral Neuroimmune Mechanisms of Hyperthermia

Ap rekrite
  • Massachusetts General Hospital Depression Clinical & Research Program, Boston
Laj 18 a 65 · Tout sèks · Mizajou Mar 10, 2023 · NCT05366270

Etid Twoub depresif majè nan lòt vil

Lòt etid nan Boston

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.